Lasocki Arian, Gaillard Frank, Tacey Mark, Drummond Katharine, Stuckey Stephen
Department of Cancer Imaging, Peter MacCallum Cancer Centre, East Melbourne, Vic 3002, Australia; Monash Imaging, Monash Health, Clayton, Vic 3168, Australia.
Department of Radiology, The Royal Melbourne Hospital, Parkville, Vic 3052, Australia; Department of Radiology, The University of Melbourne, Parkville, Vic 3052, Australia.
J Clin Neurosci. 2016 Sep;31:92-8. doi: 10.1016/j.jocn.2016.02.022. Epub 2016 Jun 21.
Glioblastoma usually presents on imaging as a single peripherally enhancing lesion, but multiple enhancing lesions can occur, termed multifocal if there is a connection between enhancing lesions, or multicentric when no communication is demonstrated. We aim to determine the incidence and prognostic implications of multifocal and multicentric glioblastoma in the era of modern MRI, focusing on the added benefit of T2-weighted fluid-attenuated inversion recovery (FLAIR) imaging. Patients with a new diagnosis of glioblastoma were identified. Preoperative MRI were reviewed to determine whether more than one distinct enhancing lesion was present, and whether there was communication between lesions. The findings were compared against survival data. More than one discrete contrast-enhancing lesion was present in 51 of the 151 patients (34%). Communication between lesions was identified in 47 of these, most commonly direct parenchymal spread (41 patients). The patients with multiple lesions had worse survival (median 176days, compared to 346days), but this difference was not statistically significant (p=0.253). These tumours more frequently involved deep structures (p<0.001) and the posterior fossa (p=0.045), both of which were associated with worse survival. The presence of multiple enhancing foci in glioblastoma is common, occurring in about one-third of patients, and the majority have multifocal disease. The FLAIR sequence is the crucial sequence for demonstrating a communication between lesions. The worse survival of these patients is, at least in large part related to more extensive tumour dissemination and more frequent involvement of key structures, rather than multiplicity per se.
胶质母细胞瘤在影像学上通常表现为单个周边强化病灶,但也可出现多个强化病灶。如果强化病灶之间存在连接,则称为多灶性;如果未显示病灶之间有连通,则称为多中心性。我们旨在确定现代MRI时代多灶性和多中心性胶质母细胞瘤的发病率及预后意义,重点关注T2加权液体衰减反转恢复(FLAIR)成像的附加益处。确定了新诊断为胶质母细胞瘤的患者。回顾术前MRI以确定是否存在不止一个明显的强化病灶,以及病灶之间是否有连通。将这些结果与生存数据进行比较。151例患者中有51例(34%)存在不止一个离散的对比增强病灶。其中47例病灶之间存在连通,最常见的是直接脑实质扩散(41例患者)。有多个病灶的患者生存情况较差(中位生存期176天,而单病灶患者为346天),但这种差异无统计学意义(p=0.253)。这些肿瘤更常累及深部结构(p<0.001)和后颅窝(p=0.045),而这两者均与较差的生存相关。胶质母细胞瘤中存在多个强化灶很常见,约三分之一的患者会出现,且大多数为多灶性疾病。FLAIR序列是显示病灶之间连通的关键序列。这些患者较差的生存情况至少在很大程度上与肿瘤更广泛的播散和关键结构更频繁的受累有关,而非单纯的病灶数量。